FONT-SIZE Plus   Neg

Anacor Pharma Prices Public Offering Of 3.13 Mln Shares At $6.39/shr

Anacor Pharmaceuticals (ANAC) announced that it has priced an underwritten public offering of 3.13 million shares of its common stock at a price to the public of $6.39 per share for gross proceeds of $20.0 million.

Anacor has also granted the underwriters a 30-day option to purchase up to 15 percent of the shares of common stock offered in the public offering to cover over-allotments.

The company said it expects to use the net proceeds from the sale of the shares for research and development activities, working capital and general corporate purposes. All of the shares in the offering will be sold by Anacor. The offering is expected to close on May 1, 2013, subject to satisfaction of customary closing conditions.

Cowen and Company, LLC is acting as the sole book-running manager for the offering. Canaccord Genuity Inc. and Wedbush Securities Inc. are acting as co-managers for the offering.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Follow RTT